Simultaneous inhibition of ATR and PARP sensitizes colon cancer cell lines to irinotecan
Enhanced DNA damage repair is one mechanism involved in colon cancer drug resistance. Thus, targeting molecular components of repair pathways with specific small molecule inhibitors may improve the efficacy of chemotherapy. ABT-888 and VE-821, inhibitors of poly-ADP-ribose-polymerase (PARP) and the...
Main Authors: | Abu-Sanad, Atlal, Wang, Yunzhe, Hasheminasab, Fatemeh, Panasci, Justin, Noë, Alycia, Rosca, Lorena, Davidson, David, Amrein, Lilian, Sharif-Askari, Bahram, Aloyz, Raquel, Panasci, Lawrence |
---|---|
Format: | Online |
Language: | English |
Published: |
Frontiers Media S.A.
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510998/ |
Similar Items
-
Small Molecules, Inhibitors of DNA-PK, Targeting DNA Repair, and Beyond
by: Davidson, David, et al.
Published: (2013) -
Is There an Epigenetic Component Underlying the Resistance of Triple-Negative Breast Cancers to Parp Inhibitors?
by: Lovato, Amanda, et al.
Published: (2012) -
Ki 67 is a major, but not the sole determinant of Oncotype Dx recurrence score
by: Sahebjam, S, et al.
Published: (2011) -
Pharmacological targeting of eIF4E in primary CLL lymphocytes
by: Martinez-Marignac, V, et al.
Published: (2013) -
Non-thermal plasma-induced apoptosis is modulated by ATR- and PARP1-mediated DNA damage responses and circadian clock
by: Choi, Ji Ye, et al.
Published: (2016)